Overview

Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)

Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
To assess clinical efficacy and safety of long-term orally administered thioctic acid in the treatment of diabetic polyneuropathy.
Phase:
Phase 3
Details
Lead Sponsor:
MEDA Pharma GmbH & Co. KG
Collaborators:
Clinquest, Inc.
Ergomed
Quintiles, Inc.
Treatments:
Thioctic Acid